Drug Study 82d2p

DRUG STUDY Student’s name: Area : Patient’s name : L. B. P. Room/bed No. : OB Ward Age : 36 years old

GENERIC NAME

Ferrous Sulfate

Date of Submission Clinical Instructor Physician Date of ission Hospital No.

BRAND NAME

CLASSIFICATION

MECHANISM OF ACTION

Sorbifer

Antianemic

Iron is absorbed from the duodenum and upper jejunum by an active mechanism through the mucosal cells where it combines with the protein transferring. Iron is stored in the body

CONTRAINDICATION

Hemosiderosis, hemochromatosis, peptic ulcer, regional enteritis, and ulcerative colitis, hemolytic anemia, pyridoxine responsive anemia, and cirrhosis of

SIDE EFFECTS

GI: Constipation, gastric irritation, N&V, abdominal cramps, anorexia, diarrhea, and dark-colored stools. These effects may be minimized by istering preparations as a coated

: September 26, 2008 : : : August 8, 2008 :

HOW SUPPLIED

Tablets: 325 mg Drops: 75mg/0.6ml

Elixir: 220mg/5ml Liquid: 300mg/5ml

DOSAGE AND FREQUENCY

NURSING RESPONSIBILITIES

1 tab OD P.O.

Before: -Perform hand washing - physician’s order -Prepare medication During : -Identify patient -Assess client in semi-fowler’s position -Assess in istering the medication

as hemosiderin or aggregated ferritin which is found in reticuloendothelial cells of the liver, spleen, and bone marrow. About twothirds of total body iron is in the circulating RBCs in hemoglobin.

the liver. Use in those with normal iron balance.

tablet. Soluble iron preparations may stain the teeth.

to the patient -Position client in comfortable position After: -Document istration on medication -Assess patient 30-60 minutes after istration and document the patient’s response to medication

(Spratto, et al; 2008: 619) Cefalexin

Panixine

Cephalosporin

Interferes with the final step in cell wall formation (inhibition of

Hypersensitivity to cephalosporins or related antibiotics.

GI: N&V, diarrhea, abdominal cramps or pain, sore

Capsules: 250 mg, 333 mg, 500 mg, 750 mg

1 cap 500 mg TID P.O.

Before: - Assess patient’s condition -Perform hand washing

mucopeptide biosynthesis) , resulting in unstable cell membranes that undergo lysis. In addition, cell division and growth are inhibited. (Spratto, et al; 2008: 278)

mouth or tongue, anorexia Allergic: Urticaria rashes, pruritus, fever, chills, t pain, chills, myalgia Hematologic: Leukopenia, neutropenia, eosinophilia CNS: Headache, malaise, fatigue, dizziness, confusion Hepatic: Hepatomegaly, hepatitis

Powder for oral suspension 125mg/5ml 250mg/5ml

- physician’s order -Prepare medication

Tablets: 250 mg, 500 mg

During : -Identify patient -Assess client in semi-fowler’s position -Assess in istering the medication to the patient -Position client in comfortable position

Tablets for oral suspension 125 mg, 250 mg

After: -Document istration on medication -Assess patient 30-60 minutes after istration and document the patient’s response to medication

Mefenamic acid

Ponstan

Nonsteroidal antiinflammatory drug

Possesses antiinflammatory , antipyretic and analgesic properties. Known to inhibit both prostaglandi n and leukotriene synthesis, to have antibradykinin activity and to stabilize lysosomal membranes. (Spratto, et al; 2008: 1845)

Hypersensit ivity to ketorolac; individuals with complete or partial syndrome of nasal polyps, angioedema, and bronchospastic reaction to aspirin

GI: Peptic ulcer, GI bleeding, nausea, diarrhea, constipation, abdominal pain, anorexia, vomiting, stomatitis CNS: Headache CV: Peripheral edema, fluid retention

Capsules: 250 mg

1 cap 500 mg every 6 hours P.O

Before: - Assess patient’s condition -Perform hand washing - physician’s order -Prepare medication During : -Identify patient -Assess client in semi-fowler’s position -Assess in istering the medication to the patient After: -Document -Assess patient 30-60 mins. after istration and document response to medication

Pitocin Oxytocin Oxytocic drug

Acts on smooth muscle of the uterus to stimulate contractions: response depends on the uterine threshold of excitability. It is selective for the uterus, especially toward the end of pregnancy, during labor, and immediately following delivery. Oxytocin

Mother: CV: Cardiac arrhythmia, Hypersensit hypertensive ivity to drug. episodes Significant cephalopelv GI: ic N&V, disproportio abdominal n; pain, unfavorable cramping fetal positions or CNS: presentatio headache, ns that are dizziness undeliverabl e without GU: conversion Pelvic prior to hematoma, delivery. post-partum hemorrhage Fetus: CV: Bradycardia, arrythmias

Before: - Assess patient’s condition -Perform hand washing - physician’s order -Prepare medication

Injection: 10 units/ml

.

During : -Identify patient -Assess client in semi-fowler’s position -Assess in istering the medication to the patient -Position client in comfortable position After: -Document istration on medication

stimulates rhythmic contractions of the uterus, increases the frequency of existing contractions and raises the tone of uterine musculature. (Spratto, et al; 2008: 1181)

CNS: Permanent CNS or brain damage, neonatal seizures GI: Peptic ulcer, GI bleeding, nausea, diarrhea, constipation, abdominal pain, anorexia, vomiting, stomatitis CNS: Headache CV: Peripheral edema, fluid retention

-Assess patient 30-60 minutes after istration and document the patient’s response to medication